Convergent dysregulation of frontal cortical cognitive and reward systems in eating disorders

. 2013 May 10 ; 19 () : 353-8. [epub] 20130510

Jazyk angličtina Země Spojené státy americké Médium electronic

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid23660852

A substantive literature has drawn a compelling case for the functional involvement of mesolimbic/prefrontal cortical neural reward systems in normative control of eating and in the etiology and persistence of severe eating disorders that affect diverse human populations. Presently, we provide a short review that develops an equally compelling case for the importance of dysregulated frontal cortical cognitive neural networks acting in concert with regional reward systems in the regulation of complex eating behaviors and in the presentation of complex pathophysiological symptoms associated with major eating disorders. Our goal is to highlight working models of major eating disorders that incorporate complementary approaches to elucidate functionally interactive neural circuits defined by their regulatory neurochemical phenotypes. Importantly, we also review evidence-based linkages between widely studied psychiatric and neurodegenerative syndromes (e.g., autism spectrum disorders and Parkinson's disease) and co-morbid eating disorders to elucidate basic mechanisms involving dopaminergic transmission and its regulation by endogenously expressed morphine in these same cortical regions.

Zobrazit více v PubMed

American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000.

Wildes JE, Marcus MD. Alternative methods of classifying eating disorders: Models incorporating comorbid psychopathology and associated features. Clin Psychol Rev. 2013;33:383–94. PubMed PMC

Neary MT, Batterham RL. Gaining new insights into food reward with functional neuroimaging. Forum Nutr. 2010;63:152–63. PubMed

De Silva A, Salem V, Matthews PM, Dhillo WS. The use of functional MRI to study appetite control in the CNS. Exp Diabetes Res. 2012;2012:764017. PubMed PMC

Hollmann M, Hellrung L, Pleger B, et al. Neural correlates of the volitional regulation of the desire for food. Int J Obes (Lond) 2012;36:648–55. PubMed

Tomasi D, Volkow ND. Striatocortical pathway dysfunction in addiction and obesity: differences and similarities. Crit Rev Biochem Mol Biol. 2013;48:1–19. PubMed PMC

Fladung AK, Gron G, Grammer K, et al. A neural signature of anorexia nervosa in the ventral striatal reward system. Am J Psychiatry. 2010;167:206–12. PubMed

Joseph RJ, Alonso-Alonso M, Bond DS, et al. The neurocognitive connection between physical activity and eating behaviour. Obes Rev. 2011;12:800–12. PubMed PMC

Van den Eynde F, Claudino AM, Campbell IC, Schmidt U. Immediate cognitive effects of repetitive Transcranial Magnetic Stimulation in eating disorders: a pilot study. Eat Weight Disord. 2011;16:e45–48. PubMed

Gaudio S, Quattrocchi CC. Neural basis of a multidimensional model of body image distortion in anorexia nervosa. Neurosci Biobehav Rev. 2012;36:1839–47. PubMed

van KK, Gerard N, Van LK, et al. Towards a neurocircuitry in anorexia nervosa: evidence from functional neuroimaging studies. J Psychiatr Res. 2009;43:1133–45. PubMed

Cascio CJ, Foss-Feig JH, Heacock JL, et al. Response of neural reward regions to food cues in autism spectrum disorders. J Neurodev Disord. 2012;4:9. PubMed PMC

Joutsa J, Martikainen K, Niemela S, et al. Increased medial orbitofrontal [18F]fluorodopa uptake in Parkinsonian impulse control disorders. Mov Disord. 2012;27:778–82. PubMed

Vilas D, Pont-Sunyer C, Tolosa E. Impulse control disorders in Parkinson’s disease. Parkinsonism Relat Disord. 2012;18(Suppl 1):S80–84. PubMed

Kontis D, Theochari E. Dopamine in anorexia nervosa: a systematic review. Behav Pharmacol. 2012;23:496–515. PubMed

Stice E, Yokum S, Zald D, Dagher A. Dopamine-based reward circuitry responsivity, genetics, and overeating. Curr Top Behav Neurosci. 2011;6:81–93. PubMed

Ziauddeen H, Chamberlain SR, Nathan PJ, et al. Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects. Mol Psychiatry. 2012 [Epub ahead of print] PubMed PMC

Uher R, Brammer MJ, Murphy T, et al. Recovery and chronicity in anorexia nervosa: brain activity associated with differential outcomes. Biol Psychiatry. 2003;54:934–42. PubMed

Uher R, Murphy T, Brammer MJ, et al. Medial prefrontal cortex activity associated with symptom provocation in eating disorders. Am J Psychiatry. 2004;161:1238–46. PubMed

Wagner A, Ruf M, Braus DF, Schmidt MH. Neuronal activity changes and body image distortion in anorexia nervosa. Neuroreport. 2003;14:2193–97. PubMed

Seeger G, Braus DF, Ruf M, et al. Body image distortion reveals amygdala activation in patients with anorexia nervosa – a functional magnetic resonance imaging study. Neurosci Lett. 2002;326:25–28. PubMed

Uher R, Murphy T, Friederich HC, et al. Functional neuroanatomy of body shape perception in healthy and eating-disordered women. Biol Psychiatry. 2005;58:990–97. PubMed

Kurosaki M, Shirao N, Yamashita H, et al. Distorted images of one’s own body activates the prefrontal cortex and limbic/paralimbic system in young women: a functional magnetic resonance imaging study. Biol Psychiatry. 2006;59:380–86. PubMed

Miyake Y, Okamoto Y, Onoda K, et al. Brain activation during the perception of distorted body images in eating disorders. Psychiatry Res. 2010;181:183–92. PubMed

Zastrow A, Kaiser S, Stippich C, et al. Neural correlates of impaired cognitive-behavioral flexibility in anorexia nervosa. Am J Psychiatry. 2009;166:608–16. PubMed

Friederich HC, Herzog W. Cognitive-behavioral flexibility in anorexia nervosa. Curr Top Behav Neurosci. 2011;6:111–23. PubMed

Cherkasova MV, Hechtman L. Neuroimaging in attention-deficit hyperactivity disorder: beyond the frontostriatal circuitry. Can J Psychiatry. 2009;54:651–64. PubMed

Emond V, Joyal C, Poissant H. [Structural and functional neuroanatomy of attention-deficit hyperactivity disorder (ADHD)]. Encephale. 2009;35:107–14. PubMed

Wang L, LaBar KS, Smoski M, et al. Prefrontal mechanisms for executive control over emotional distraction are altered in major depression. Psychiatry Res. 2008;163:143–55. PubMed PMC

Barbalat G, Chambon V, Franck N, et al. Organization of cognitive control within the lateral prefrontal cortex in schizophrenia. Arch Gen Psychiatry. 2009;66:377–86. PubMed

Wessa M, Linke J. Emotional processing in bipolar disorder: behavioural and neuroimaging findings. Int Rev Psychiatry. 2009;21:357–67. PubMed

Oberndorfer TA, Kaye WH, Simmons AN, et al. Demand-specific alteration of medial prefrontal cortex response during an inhibition task in recovered anorexic women. Int J Eat Disord. 2011;44:1–8. PubMed

Lock J, Garrett A, Beenhakker J, Reiss AL. Aberrant brain activation during a response inhibition task in adolescent eating disorder subtypes. Am J Psychiatry. 2011;168:55–64. PubMed PMC

Schulte-Ruther M, Mainz V, Fink GR, et al. Theory of mind and the brain in anorexia nervosa: relation to treatment outcome. J Am Acad Child Adolesc Psychiatry. 2012;51:832–41. PubMed

Kaye WH, Wierenga CE, Bailer UF, et al. Nothing tastes as good as skinny feels: the neurobiology of anorexia nervosa. Trends Neurosci. 2013;36:110–20. PubMed PMC

Brooks SJ, O’Daly OG, Uher R, et al. Differential neural responses to food images in women with bulimia versus anorexia nervosa. PLoS One. 2011;6:e22259. PubMed PMC

Brooks SJ, O’Daly O, Uher R, et al. Thinking about eating food activates visual cortex with reduced bilateral cerebellar activation in females with anorexia nervosa: an fMRI study. PLoS One. 2012;7:e34000. PubMed PMC

Oldershaw A, Treasure J, Hambrook D, et al. Is anorexia nervosa a version of autism spectrum disorders? Eur Eat Disord Rev. 2011;19:462–74. PubMed

Kaye WH, Frank GK, Bailer UF, et al. Serotonin alterations in anorexia and bulimia nervosa: new insights from imaging studies. Physiol Behav. 2005;85:73–81. PubMed

Kaye WH, Bailer UF, Frank GK, et al. Brain imaging of serotonin after recovery from anorexia and bulimia nervosa. Physiol Behav. 2005;86:15–17. PubMed

Bailer UF, Kaye WH. Serotonin: imaging findings in eating disorders. Curr Top Behav Neurosci. 2011;6:59–79. PubMed PMC

Frank GK, Bailer UF, Henry SE, et al. Increased dopamine D2/D3 receptor binding after recovery from anorexia nervosa measured by positron emission tomography and [11c]raclopride. Biol Psychiatry. 2005;58:908–12. PubMed

Bailer UF, Frank GK, Price JC, et al. Interaction between serotonin transporter and dopamine D2/D3 receptor radioligand measures is associated with harm avoidant symptoms in anorexia and bulimia nervosa. Psychiatry Res. 2013;211:160–68. PubMed PMC

Stefano GB, Kraliekova M, Ptacek R, et al. Low dose morphine adjuvant therapy for enhanced efficacy of antipsychotic drug action: Potential involvement of endogenous morphine in the pathophysiology of schizophrenia. Med Sci Monit. 2012;18(7):HY23–26. PubMed PMC

Bralet MC, Navarre M, Eskenazi AM, et al. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Encephale. 2008;34:557–62. PubMed

Minzenberg MJ, Laird AR, Thelen S, et al. Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. Arch Gen Psychiatry. 2009;66:811–22. PubMed PMC

Semkovska M, Bedard MA, Stip E. [Hypofrontality and negative symptoms in schizophrenia: synthesis of anatomic and neuropsychological knowledge and ecological perspectives]. Encephale. 2001;27:405–15. PubMed

Stip E. [Cognition, schizophrenia and the effect of antipsychotics]. Encephale. 2006;32:341–50. PubMed

Kaye WH, Wierenga CE, Bailer UF, et al. Does a Shared Neurobiology for Foods and Drugs of Abuse Contribute to Extremes of Food Ingestion in Anorexia and Bulimia Nervosa? Biol Psychiatry. 2013;73(9):836–42. PubMed PMC

Yamamotova A, Papezova H, Uher R. Modulation of thermal pain perception by stress and sweet taste in women with bulimia nervosa. Neuro Endocrinol Lett. 2009;30:237–44. PubMed

Marrazzi MA, Luby ED, Kinzie J, et al. Endogenous codeine and morphine in anorexia and bulimia nervosa. Life Sci. 1997;60:1741–47. PubMed

Kmoch V, Papezova H, Yamamotova A. Two patients with eating disorders treated by naltrexone. Neuro Endocrinol Lett. 2009;30:327–30. PubMed

Holanova P, Papezova H, Sekot M. Addiction to analgesic on. Eating Disorders. 2013:B20.

Giuliano C, Robbins TW, Nathan PJ, et al. Inhibition of opioid transmission at the mu-opioid receptor prevents both food seeking and binge-like eating. Neuropsychopharmacology. 2012;37:2643–52. PubMed PMC

Bandelow B, Schmahl C, Falkai P, Wedekind D. Borderline personality disorder: a dysregulation of the endogenous opioid system? Psychol Rev. 2010;117:623–36. PubMed

Stefano GB, Ptacek R, Kuzelova H, Kream RM. Endogenous morphine: Up-to-date review 2011. Folia Biolo (Praha) 2012;58:49–56. PubMed

Stefano GB, Kream RM. Reciprocal regulation of cellular nitric oxide formation by nitric oxide synthase and nitrite reductases. Med. Sci Monit. 2011;17(10):RA221–26. PubMed PMC

Bianchi E, Guarna M, Tagliamonte A. Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol. 1994;4:83–92. PubMed

Laux A, Muller AH, Miehe M, et al. Mapping of endogenous morphine-like compounds in the adult mouse brain: Evidence of their localization in astrocytes and GABAergic cells. J Comp Neurol. 2011;519:2390–416. PubMed

Hautzel H, Muller HW, Herzog H, Grandt R. Cognition-induced modulation of serotonin in the orbitofrontal cortex: a controlled cross-over PET study of a delayed match-to-sample task using the 5-HT2a receptor antagonist [18F]altanserin. Neuroimage. 2011;58:905–11. PubMed

Rasmussen H, Erritzoe D, Andersen R, et al. Decreased frontal serotonin2A receptor binding in antipsychotic-naive patients with first-episode schizophrenia. Arch Gen Psychiatry. 2010;67:9–16. PubMed

Lopez-Gimenez JF, Vilaro MT, Milligan G. Morphine desensitization, internalization, and down-regulation of the mu opioid receptor is facilitated by serotonin 5-hydroxytryptamine2A receptor coactivation. Mol Pharmacol. 2008;74:1278–91. PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...